Cargando…
Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration
BACKGROUND: In 4 decades, numerous nicotine replacement therapy products have been developed. Population pharmacokinetic models can support exposure–response modeling and inform nicotine replacement therapy product development, but only limited model-based cross-study population pharmacokinetic anal...
Autores principales: | Olsson Gisleskog, Per O., Perez Ruixo, Juan José, Westin, Åke, Hansson, Anna C., Soons, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016787/ https://www.ncbi.nlm.nih.gov/pubmed/33354734 http://dx.doi.org/10.1007/s40262-020-00960-5 |
Ejemplares similares
-
Genetic and Pharmacokinetic Determinants of Response to Transdermal Nicotine in White, Black and Asian Non-Smokers
por: Dempsey, Delia A., et al.
Publicado: (2013) -
Pharmacokinetics of Intravenous, Intramuscular, Oral, and Transdermal Administration of Flunixin Meglumine in Pre-wean Piglets
por: Kittrell, Heather C., et al.
Publicado: (2020) -
Nicotine Population Pharmacokinetics in Healthy Adult Smokers: A Retrospective Analysis
por: Marchand, Mathilde, et al.
Publicado: (2017) -
Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis
por: Chen, P, et al.
Publicado: (2016) -
Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers
por: Rasmussen, Scott, et al.
Publicado: (2018)